NextCure (NASDAQ:NXTC) Receives Buy Rating from HC Wainwright
NextCure (NASDAQ:NXTC – Get Free Report)‘s stock had its “buy” rating restated by stock analysts at HC Wainwright in a research note issued on Friday,Benzinga reports. They presently have a $3.00 price objective on the stock, down from their prior price objective of $4.00. HC Wainwright’s price objective points to a potential upside of 300.00% […]
NextCure (NASDAQ:NXTC – Get Free Report)‘s stock had its “buy” rating restated by stock analysts at HC Wainwright in a research note issued on Friday,Benzinga reports. They presently have a $3.00 price objective on the stock, down from their prior price objective of $4.00. HC Wainwright’s price objective points to a potential upside of 300.00% […]
